An Open-Label Randomized Phase III Trial of BMS-936558 (Nivolumab) Versus Docetaxel in Previously Treated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)
收藏DataCite Commons2026-01-21 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012682/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of the study is to compare the overall survival of BMS-936558 (Nivolumab) as compared with Docetaxel in subjects with non-squamous cell non-small cell lung cancer (NSCLC) after failure of prior platinum-based chemotherapy
提供机构：
Vivli
创建时间：
2026-01-21
